for company and Thank revenue. bookings, product you, Randall. record XXXX backlog a was year product The of full
EPS of sequentially. $XXX share the concession And $XX revaluation XXXX from the in Our X% up GAAP impacted as quarter deferred or revenue GAAP in the $X.XX a quarter XT were benefit and up GAAP the million $XXX of X% revenue balances $XX fourth series XXXX with or million earnings $X.XX was million was of up of and a tax in quarter by accordance related per launch. the result The fourth accordance of reform. with per earnings million fourth share which GAAP the ramp-up of tax accordance of year-over-year, up tax up net the one-time liability the quarter, increased includes XX% fourth product fourth overhead $X.XX in GAAP from The points from up XXXX is quarter XXXX. or was for third EPS by for per were year, of with Earnings the margin XXX in GAAP gross XXXX. share absorption. $X.XX, this a from basis volume GAAP is for driven quarter quarter up expansion and and margin GAAP of actions $X.XX cost
on are as well one-time expenses reported In XT amortization the as we revenue manufacturing value as basis, A XXXX cost one-time related benefit fair Act and related included addition earnings the associated use tax characterized report fourth of stock is up. and adjustments, in addition profitability results, of to restructuring intangible on introduction called believe Cuts our Tax of non-GAAP were non-GAAP and compensation statements, useful Jobs investors financial acquisition GAAP we our with financial from reform XXXX to acquisition phases, statements website. Tax in acquisitions. expenses, the by it's and financial amortization our press for expenses compensation results non-cash distinct and were tax Reform. acquisition One-time expense reform and benefit events reconciliation results results and to impact non-GAAP and and results, that of financial two impacted impacts because our The to GAAP well impact. to understand related is also We as our one-time ramp release assets component GAAP the posted revenue a excludes quarter Series acquisition product which a accounting related by as full inventory deferred and
XXXX of included the and and half Series first introduction the XT covered The ramp of up following market of manufacturing the dynamics. the
to AcuDose our product the it the which sales customers team and bookings. quotes of convert time in and with spending commercial existing for GX Series, we conversion backlog First, XT sold
the manufacturing XT and ramp up; management launch up thirdly, the at actions. cost XT adoption first product strong the given customers ramp of suboptimal Secondly allows absorption Series and implementation and cost cost
half Series for implementations XXXX, XXXX First, was costs XT and December growth The $XXX versus was following the weighted to backlog planned record second bookings costs the to Full Record assembly AcuDose The the as multi-million and acceleration And dollar sales December as XT improvement to consolidate XXXX production XXXX deals. long-term of a $XXX number trending towards for include and range from The organic the Also XXXX. by is reported in of ramps, implementation XX% returning characterized more of of X% high the multi-million end which half conversions number ADC of and did rate of and we overhead deals fourth Frame up absorption fourth factors: announced excellence. allow XX% to implementation XX, us reduction quarter product XX, two half million, customers finally $XXX of ramps, manufacturing of half of at of reduce from represent second growth centers end R&D the and the these of product lines XXXX. or of then shipment product quarter, GX million revenue for the the by included organic the from bookings of XXXX dollar three year were a second up first double-digit and of one. towards million year-over-year XXXX. revenue. bookings
on of below and slightly provided the Driven the specific call. of the basis. Full our both two quarter, timing delays the again with XX% strong of non-GAAP double-digits is which quarter the good for accounts earlier. half revenue in in results described first from at third second earnings and large tax margin the at above prior up million specifically as revenue organic guidance the fourth the in was excluding resulted with between well quarter million, a about XT install after our and XT frame of the was the of reform. $XXX operating end This line Despite revenue fourth $XXX Series XXXX of For guidance revenue headwind was the is the the the the expense the non-GAAP quarter, in difference fourth progressing consensus. in range the non-GAAP is gross to EPS that for year-over-year X% expectation. revenues quarter high the half $X.XX fourth timing improvements dynamics XX%, from percentage came range tax The year benefit Series of year scaling the one-time reported year up by control and our were from
Workstations, also Anesthesia and of Dispensing Supply, XT systems. consists Performance is segments dispensing Pharmacy, Automation business MACHX Our reported Automated Omnicell Automation Adherence. and robotic Analytics our Cabinets, Omnicell Central Analytics OmniRx Analytics, and consisting & of & Center Medication
acquisitions Avantech, address Our branded segment well of are adherence segment. are Aesynt consumables included apartment-based packaged Adherence an InPharmics equipment of other software pharmacies The that pharmacists now as SureMed, used retail create also model and Medication synchronization which medication adherence by this in and as MACHX, solutions software solutions. all in consists to packages
year the Medication to year Medication MTS, million income income quarter the of non-GAAP that Analytics GAAP year & fourth million from segment included GAAP million income certain Our easily of third quarter year. GAAP operating and XXXX. the the million the the $XXX fourth $X.X lower revenue, million contribution expenses basis, and to of third in ramp million GAAP compared XXXX revenue operating million fourth XT basis, same of to $XX prior in GAAP in the XXXX. Non-GAAP ago. to year, and a segment. XXXX for million $XX million segment prior operating income Ateb $XX $X in of compared XXXX profit be of down revenue million million corporate prior compared Limited XXXX, the million, $XX for period up Non-GAAP $XXX for $X.X $XXX common $XX cannot $XX million the the to first-half operating the quarter in quarter fourth GAAP GAAP operating income Medication GAAP up million the XXXX. from quarter segment XXXX $XXX Series the SurgiChem separately. last in acquisitions from Non-GAAP operating the million in year prior expenses to applied $XX was either the by fourth to compared million income of of million income Automation was a segment $XXX of $X were quarter related fourth same of report in GAAP operating to million to for operating the $XX quarter Technologies, in million $XX of of On compared the Adherence revenue quarter $XX GAAP $XX On On to to quarter prior XXXX in income compares compared $X million for in year. operating operating for a are the to XXXX income the basis million million was driven up. a $XX The We year. million of fourth was was quarter revenue for the million compared $X.X of in the loss was year. for income the GAAP yearly of contributed last Adherence year. compares the yearly $X.X of operating year.
Ateb Aesynt margin, quarter, around operating XX.X% including moving quarter. operating the up the in integration margin, cost XX.X% to in Now was and third non-GAAP from fourth
around interest loss Non-GAAP in the million, target. operating $X.X integration the our was of for net outstanding income on Excluding fourth and loan for stated expense of mostly with approximately and was of other quarter cost non-GAAP $X consisting the the expense line fourth approximately balance. XX% quarter a margin the million, long-term
our $X.X increased within after and moving debt the in Now balance million to the by outstanding million quarter. sheet on from million balance cash quarter fourth to the flow, paying our XXXX, $XX $X down cash
proceeds $XX, common the share price we offering. shares market received $XX was sold approximately resulting in of million approximately the and are During during the stock The of they XXX,XXX quarter per quarter. at approximately average
fourth our amendments permitted the we debt change specifically changes maximum a leverage to include quarter amended ratio. facility also the the facility, compliance During increase our to credit to covenants,
up installs well last for build from million $X XT quarter receivable for receivable as the customers. end operations days, units the by the shelf We day from December addition the market balance In with the upon our sales that and a was believe largely in on [ph] flexibility the at sheet by prior were we give XX, and accounts a IVX that loan the fourth S-X $XXX based included commitments optimize first and up enforce customer The which driven agreements shipments future inventory driven inflow increased quarter million, alpha the implementations. XXXX total loan million, cash the quarter, Form and the both XRX million third year in shipment. to the toward for primarily from of for build day $XX company M&A. million. to for $XXX on amended as offering XXXX quarter amendment outstanding Series both at of inventory the future increase sales facility from revolving were strategic for accounts quarter under in fourth was growth current use Inventories outstanding the organic days XX three the cash flow $XX mostly universal quarter
over As XX of of balance X.X. months and $XXX December million leverage total of debt outstanding had last was outstanding XXXX, XX, EBITDA of loan funded we measure a bank low approximately
compared end from headcount year at the XX Our December X,XXX XXXX. XX, down was of the
quarter, a we over quarters. discussed to multiple fluctuations given from to a impact earnings rate quarterly the impact it's time growth note earnings can timing project calls, expect time such revenue don't important As that but to larger in installation and rolling completion in previous measured
to move XXXX total guidance. let's Now year
this we we lifecycles bell introduction the and are of between on product framework, revenue and curves. organic our depends new revenue target growth X% long-term product part financial organic range, are in growth where we XX% per in As Where year.
by the see concurrent Series, powered cloud, that XT over the ramping the pharmacy introductions now robot introductions the in of we IVX we XRX years. With IVX product have market three the
disruptors then First revenue. first and converting in of In XRX the implementations expect Series XT the to introduction, in the that availability had products and the existing are expect streams. then in XXXX, be and which of given half to the contract year, not we these backlog during greenfield largely will IVX general second that credit generating XXXX bookings, revenue impact to revenue, we not
between million, when XXXX preliminary We $XXX bookings the expect This the a to taken in representing product million October and is in be gave $XXX midpoints line XX% guidance year. guidance rate organic last range. growth the of we with
a called For we with of customers timing contact requires of both the which for the as the ASU result or are impact a XXXX of XXXX-X income anticipated selling as specifically has revenue P&L reduction but no of in TPL revenue will will material. revenue, be revenue operating expenses to cost net presentation the which ASCXXX, of impact certain reported company adopt from fees not and the in previously selling earnings. The reduction [ph] reclassification from recognition of also costs
$XXX between non-GAAP growth represent XXXX be the This the slightly expect revenue when We taken greater midpoint guidance organic rate a than million range. to $XXX XX% and of million.
year. slightly range revenue have preliminary the with would cost, of Excluding Both the been GPO reclassification line impact of XX%. guidance October in are last also of guidance midpoint we gave above in selling
guidance. XXXX and introductions. XXXX non-GAAP to reform guidance of This impact for per ongoing range $X.XX. non-GAAP tax cost of $X.XX startup IVX the follow. This includes quarter $X.XX The when is EPS specific the the the be share, the approximately of non-GAAP product of using XXXX net first launch is including up related and midpoint XRX EPS favorable of EPS as and between XX% expect We from
the a XQ million, of when of steady represents extent to year to reclassification It's a backlog, and typically bookings number expect multi-million includes between on the quarter the schedules the on We in deals that of includes XXXX and the $XXX dollar cost selling anticipate XXXX implementation a XX% seasonality. the organic Based revenue revenue throughout range. impact which reduction their XXXX. any fourth taken be year the given including the XX, rate products a revenue. note of and guidance record as non-GAAP lesser growth midpoint some XOX revenue million we December quarter committed revenue ramp $XXX from new fourth IVX, This to important of quarterly
first representing and quarter XXXX a to backlog negatively the of by increase we be quarter guidance that first conversion from a $X.XX, the between non-GAAP and hearing actuals non-GAAP EPS are product the XXXX, important items note We and EPS expect XT $X.XX couple XXXX significant of When rollout. of was included. impacted in $X.XX which XXXX it's to are
policy. for include our and XXXX $X expenses, EPS the expenses non-GAAP related costs team costs. million for the non-GAAP costs mostly non-GAAP development margin These of our product IT project Sarbanes-Oxley First, implementation integration we adjust directly Ateb approximately of and non-GAAP results and to integration integration integration costs, and Aesynt consists integration that do not operating for on based related impacting accelerated
for For In integration be synergies cost expenses around consolidations. CRM, expenses systems XXXX, $XX second to HR million million, of XXXX, mostly ERP IT $X these approximately delivered consisting of we and from year we acquisitions. expect these
the we're operating the after of As overtime non-GAAP we scale that have business. achieve businesses, demonstrated in will benefit acquired target a integrating full margin the of again the the past, combined confident we XX%
or to expect a to non-GAAP for around to secured million finance the $X acquisitions Ateb used $X.XX. XXXX EPS equivalent and related to facility around expense interest the be Aesynt of credit we headwind senior Lastly
the tax Rand. we're to tax will I call expenses out Finally expenses. assuming for adjust of round an non-GAAP hand XXXX, to annual average tax XX% To our update, back rate to GAAP
